New study could improve testing and treatment for rare brain, spinal cord, and eye cancers

MedicalXpress | Mai 22, 2026

A new study has identified hepatitis A virus cellular receptor 1 (HAVCR1) as a biomarker that could make it easier to diagnose rare but aggressive forms of brain and eye cancer earlier and with fewer invasive tests.